(Q45758617)

15 December 2017

editorial

0 references

review article

1 reference

title

Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance (English)

1 reference

15 December 2017

0 references

1 reference

1 reference

Locarnini SA

1

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

15 December 2017

published in

Hepatology

1 reference

15 December 2017

volume

27

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

page(s)

294-297

1 reference

15 December 2017

Global status of hepatitis B immunisation

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Natural history and control of perinatally acquired hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

The clinical significance of surface antigen variants of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Retroid virus genome replication.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Novel mechanism for reverse transcription in hepatitis B viruses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Mutation rate of the hepadnavirus genome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

The hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Vaccine-induced escape mutant of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Sequence homology between retroviral reverse transcriptase and putative polymerases of hepatitis B virus and cauliflower mosaic virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

A topological model for hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Therapy for human immunodeficiency virus infection -- what have we learned?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270144

7 January 2021

Identifiers

DOI

10.1002/HEP.510270144

1 reference

15 December 2017

PubMed ID

9425951

1 reference

15 December 2017